Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06140771 · ClinicalTrials.gov registry record · NA
A Clinical Study to Assess the Gingivitis Effects of Various Dentifrices
A NA study, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
NCT06140771 is a NA study that has completed, run by Procter and Gamble. The registered enrollment target is 115 participants.
The verdict
NCT06140771, a NA study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
Study Summary
The objective of this learning clinical study is to assess the gingivitis effects of four different dentifrices over a 3-month period.
Interventions
- DRUG 0.76% Sodium Monofluorophosphate Dentifrice
- DRUG 0.454% Stannous Fluoride Dentifrice
- DRUG 1.15% Sodium Monofluorophosphate Dentifrice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2021-10-20 |
| Est. Completion | 2022-02-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06140771
The ClinicalTrials.gov registry entry for NCT06140771 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which 0.76% Sodium Monofluorophosphate Dentifrice is the first listed.
NCT06140771 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06140771 about?
NCT06140771 is a clinical study titled "A Clinical Study to Assess the Gingivitis Effects of Various Dentifrices". The objective of this learning clinical study is to assess the gingivitis effects of four different dentifrices over a 3-month period.
What is the current status of trial NCT06140771?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2021-10-20. Estimated completion is 2022-02-06.
What interventions are being tested in trial NCT06140771?
The interventions under investigation include: 0.76% Sodium Monofluorophosphate Dentifrice (DRUG), 0.454% Stannous Fluoride Dentifrice (DRUG), 1.15% Sodium Monofluorophosphate Dentifrice (DRUG).
Who is sponsoring clinical trial NCT06140771?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.